The Nvidia share price has fallen in the wake of the US tech stock sell-off, but it's still up 40% in 2025. Which direction ...

AstraZeneca (($AZN)) has held its Q3 earnings call. Read on for the main highlights of the call. AstraZeneca’s recent earnings call showcased a ...

AstraZeneca is the biggest drugmaker in Britain and its £193 billion ($253 billion) market capitalization tops the London Stock Exchange.

Under the model, set to start next year, the CMS will negotiate lower prices for Medicaid programs linked to those paid in ...

The condition, which most often affects people in warm, humid climates where fungal spores are common, can trigger nasal ...

Coverage of the drugs will expand to Medicare patients starting next year, and some lower prices will also be phased in for ...

The latest move is set to cut costs of starting oral doses of GLP-1s to as low as around $150 for certain groups of people ...

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...

Known as GLP-1 receptor agonists, the drugs have soared in popularity in recent years, but patient access has been a ...

Donald Trump has signed deals with the pharma giants Novo Nordisk and Eli Lilly to lower the prices of antiobesity drugs and ...

Pharma’s push into direct-to-patient sales is reshaping the front end of drug distribution, but wholesalers like Cencora, McKesson, and Cardinal Health remain indispensable as the backbone of the ...